ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,…
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,…
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,…
Maris-Tech Strengthens its U.S. Presence with a Strategic Appointment
January 13, 2025 09:10 ET | Source: Maris-Tech Ltd. Nir Ben Moshe…
Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Application based on TROPION-Lung05 phase 2 trial and supported by data from…
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
Raanana, Israel, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ)…
U.S. Food and Drug Administration Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo (nivolumab) Indications1,2
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given…
AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together
TIANJIN, China, Dec. 24, 2024 /PRNewswire/ -- On December 7, 2024, AIMA Technology Group…
AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together
TIANJIN, China, Dec. 24, 2024 /PRNewswire/ -- On December 7, 2024, AIMA Technology Group…
AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together
TIANJIN, China, Dec. 24, 2024 /PRNewswire/ -- On December 7, 2024, AIMA Technology Group…